• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • Vaccine Administration Law

Vaccine Administration Law

Thursday, 01 August 2019 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

Vaccine Administration Law

On 29.06.2019, NMPA minister Jiao Hong attended a press briefing – held by the general office of the NPCSC (The Standing Committee of the National People’s Congress) – regarding the vaccine administration law. Jiao Hong stated to implement a very strict administration over vaccines. The Law clearly defines a stringent management system, vaccine development, production, and circulation of vaccines. Penalties related to counterfeit or substandard vaccines are far heavier than those for general drugs.

Tagged under: NMPA, Vaccine

What you can read next

1,002 Institutions in China Qualified for Clinical Trials
Sampling Inspection
NMPA Further Clarifies Sampling Inspection Procedures for Medical Devices (Draft Amendment)
NMPA Annual Report

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Registration of Pharmaceuticals in Hong Kong
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China toothpaste filing requirements

    China Toothpaste Filing Requirements

    China Toothpaste Filing Requirements were issue...
  • Building Successful China Medtech Market Entry Strategies

    Webinar | Building Successful China Medtech Market Entry Strategies – From the Market Access Perspective

    Building successful China Medtech market entry ...
  • China cosmetic regulatory violation

    China cosmetic regulatory violation cases reported by the NMPA

    China cosmetics regulatory violation cases were...
  • China medical device real world evidence

    China medical device real world evidence increasingly important

    China medical device real-world evidence is inc...
  • china medical device ifu draft guidelines

    China Medical Device IFU Draft Guidelines released by NMPA

    China Medical Device IFU Draft Guidelines have ...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2003-2023 Cisema. All rights reserved.

TOP